{"id":"https://openalex.org/W1984041544","doi":"https://doi.org/10.1080/02791072.2007.10400617","title":"Abuse OF Olanzapine by Substance Abusers","display_name":"Abuse OF Olanzapine by Substance Abusers","alternate_titles":[],"publication_year":2007,"publication_date":"2007-09-01","ids":{"openalex":"https://openalex.org/W1984041544","doi":"https://doi.org/10.1080/02791072.2007.10400617","mag":"1984041544","pmid":"https://pubmed.ncbi.nlm.nih.gov/18159784"},"language":"en","primary_location":{"id":"doi:10.1080/02791072.2007.10400617","doi":"https://doi.org/10.1080/02791072.2007.10400617","is_oa":false,"landing_page_url":"https://doi.org/10.1080/02791072.2007.10400617","pdf_url":null,"source":{"id":"https://openalex.org/S149515109","display_name":"Journal of Psychoactive Drugs","issn_l":"0279-1072","issn":["0279-1072","2159-9777"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychoactive Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1984041544"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109093450","display_name":"Roy R. Reeves","orcid":"https://orcid.org/0009-0008-0219-6285","observed_orcids":["https://orcid.org/0009-0008-0219-6285"]},"institutions":[{"id":"https://openalex.org/I29606459","display_name":"University of Mississippi Medical Center","ror":"https://ror.org/044pcn091","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I29606459","https://openalex.org/I4210141039"]},{"id":"https://openalex.org/I368840534","display_name":"University of Mississippi","ror":"https://ror.org/02teq1165","country_code":"US","type":"education","lineage":["https://openalex.org/I368840534","https://openalex.org/I4210141039"]},{"id":"https://openalex.org/I4210144720","display_name":"G.V. (Sonny) Montgomery VA Medical Center","ror":"https://ror.org/040qrra89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210138636","https://openalex.org/I4210144720"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Roy R. Reeves","raw_affiliation_strings":["Montgomery VA Medical Center, Jackson, MS 39216, USA. roy.reeves@med.va.gov","University of Mississippi School of Medicine, Jackson, MS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Montgomery VA Medical Center, Jackson, MS 39216, USA. roy.reeves@med.va.gov","institution_ids":["https://openalex.org/I4210144720"]},{"raw_affiliation_string":"University of Mississippi School of Medicine, Jackson, MS","institution_ids":["https://openalex.org/I29606459","https://openalex.org/I368840534"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5109093450"],"corresponding_institution_ids":["https://openalex.org/I29606459","https://openalex.org/I368840534","https://openalex.org/I4210144720"],"apc_list":null,"apc_paid":null,"fwci":0.9132,"has_fulltext":false,"cited_by_count":25,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.71735059,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"39","issue":"3","first_page":"297","last_page":"299"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.4146000146865845,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.4146000146865845,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.27950000762939453,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.18160000443458557,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.9520000219345093},{"id":"https://openalex.org/keywords/substance-abuse","display_name":"substance abuse","score":0.6809999942779541},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8109999895095825},{"id":"https://openalex.org/keywords/polysubstance-use","display_name":"polydrug use","score":0.7110000252723694},{"id":"https://openalex.org/keywords/sedative-effects","display_name":"sedative effects","score":0.7360000014305115},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6940000057220459},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.8889999985694885},{"id":"https://openalex.org/keywords/recreational-drug-use","display_name":"recreational drug use","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.9457517862319946},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.6949663758277893},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.6760343313217163},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5811763405799866},{"id":"https://openalex.org/C2992175768","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Drug abuser","level":3,"score":0.5724907517433167},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45540863275527954},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.449554979801178},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.41425931453704834},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.07813581824302673}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/02791072.2007.10400617","doi":"https://doi.org/10.1080/02791072.2007.10400617","is_oa":false,"landing_page_url":"https://doi.org/10.1080/02791072.2007.10400617","pdf_url":null,"source":{"id":"https://openalex.org/S149515109","display_name":"Journal of Psychoactive Drugs","issn_l":"0279-1072","issn":["0279-1072","2159-9777"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychoactive Drugs","raw_type":"journal-article"},{"id":"pmid:18159784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18159784","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychoactive drugs","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W8820996","https://openalex.org/W122505910","https://openalex.org/W133936320","https://openalex.org/W134927359","https://openalex.org/W145199628","https://openalex.org/W1975157691","https://openalex.org/W1988186930","https://openalex.org/W2027742098","https://openalex.org/W2031366574","https://openalex.org/W2031682824","https://openalex.org/W2046815959","https://openalex.org/W2068281665","https://openalex.org/W2089001892","https://openalex.org/W2104758313","https://openalex.org/W2125906568","https://openalex.org/W2141410249","https://openalex.org/W2145376332","https://openalex.org/W2328050069","https://openalex.org/W2462280211","https://openalex.org/W3127920540","https://openalex.org/W4236038590"],"related_works":["https://openalex.org/W4240190458","https://openalex.org/W4313177493","https://openalex.org/W7095247745","https://openalex.org/W2076841065","https://openalex.org/W4281666790","https://openalex.org/W2031682824","https://openalex.org/W2013117814","https://openalex.org/W2470401933","https://openalex.org/W2089001892","https://openalex.org/W2115614438"],"abstract_inverted_index":{"Olanzapine":[0],"has":[1],"been":[2],"used":[3],"for":[4,8,21,65],"over":[5],"a":[6,33],"decade":[7],"treatment":[9],"of":[10,54,56,60,67],"schizophrenia":[11],"and":[12,42],"bipolar":[13],"disorder.":[14],"The":[15,28,63],"drug":[16],"may":[17],"have":[18],"sedative":[19],"properties":[20],"some":[22],"patients,":[23],"especially":[24],"in":[25,43],"large":[26],"doses.":[27],"case":[29],"reported":[30],"here":[31],"involves":[32],"25-year-old":[34],"male":[35],"who":[36],"abused":[37],"olanzapine,":[38],"both":[39],"by":[40,58,69],"itself":[41],"combination":[44],"with":[45],"other":[46],"drugs.":[47],"Also":[48],"described":[49],"are":[50],"the":[51],"patient's":[52],"reports":[53],"abuse":[55,66],"olanzapine":[57,68],"several":[59],"his":[61],"acquaintances.":[62],"potential":[64],"substance":[70],"abusers":[71],"is":[72],"discussed.":[73]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1984041544","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
